Register entry

Amivas, Inc

Data as of · How to read this entry

Registered sites
0
Active NDC listings
3
Live patents
2
Exclusivities
1
Countries
0
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 human prescription drug. By marketing category: DRUG FOR FURTHER PROCESSING 2, NDA 1.

Dosage formNDCs
injection, powder, for solution1
kit1
solution1
RouteNDCs
Labeller name on the listingNDCs
amivas, inc3
Exclusivity

Patents and exclusivities

2
PatentProductCoversExpiry
12121506ARTESUNATEartesunateproductFeb 2044
12390442ARTESUNATEartesunateuseFeb 2044
ProductExclusivityUntil
ARTESUNATEARTESUNATEODE-290 Orphan drugMay 2027
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
-Artesunateinjection, powder, for solution73607-002DRUG FOR FURTHER PROCESSING
ArtesunateArtesunatekit73607-011NDA
-Phosphate Buffersolution73607-003DRUG FOR FURTHER PROCESSING
Compare

Other companies listing artesunate

Enquiry

Common questions

Is Amivas, Inc FDA approved?
Amivas, Inc holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Amivas, Inc make?
3 products are listed under Amivas, Inc in the openFDA NDC Directory, most often as injection, powder, for solution; kit; solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.